Gadolinium‐free extracellular MR contrast agent for tumor imaging

By  

JOURNAL OF MAGNETIC RESONANCE IMAGING, Vol. 41, Iss. 2, 2015-02 ,pp. : 397-403

John Wiley & Sons Inc

Access to resources Recommend Favorite

Phase 3 efficacy and safety trial of gadobutrol, a 1.0 molar macrocyclic MR imaging contrast agent, in patients referred for contrast‐enhanced MR imaging of the central nervous system

By  

JOURNAL OF MAGNETIC RESONANCE IMAGING, Vol. 41, Iss. 3, 2015-03 ,pp. : 788-796

John Wiley & Sons Inc

Access to resources Recommend Favorite

Dynamic susceptibility contrast MRI with a prebolus contrast agent administration design for improved absolute quantification of perfusion

By  

MAGNETIC RESONANCE IN MEDICINE, Vol. 72, Iss. 4, 2014-10 ,pp. : 996-1006

John Wiley & Sons Inc

Access to resources Recommend Favorite

Editorial [Hot Topic: Advanced Imagings of Wallerian Degeneration, Pancreatobiliary System, Uterine Cervical Cancer, Periventricular Leukomalacia, Living Cells as well as MR Contrast Agent and QC of SPECT/CT]

By  

Current Medical Imaging Reviews, Vol. 4, Iss. 2, 2008-05 ,pp. : 70-70

Bentham Science Publishers

Access to resources Recommend Favorite

Basic mechanisms and regulation of fibrinolysis

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 13, Iss. S1, 2015-06 ,pp. : S98-S105

John Wiley & Sons Inc

Access to resources Recommend Favorite